PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 10820229-4 2000 Here we report that in primary mouse bone marrow-derived mast cells activated by ionomycin or IgE/Ag, the proinflammatory mediator IL-1 (alpha or beta) up-regulated production of IL-3, IL-5, IL-6, and IL-9 as well as TNF, i.e., cytokines implicated in many inflammatory processes including those associated with allergies and helminthic infections. Ionomycin 81-90 interleukin 1 complex Mus musculus 131-150 3262467-2 1988 When stimulated with suboptimal concentrations of ionomycin and phorbol myristate acetate (PMA), the immature subpopulation of Lyt2-,L3T4- (2-4-) thymocytes responded to exogenous, purified IL-1 in a dose-dependent manner. Ionomycin 50-59 interleukin 1 complex Mus musculus 190-194 2574679-5 1989 Similarly to plastic-adsorbed antibodies, phorbol myristic acetate (PMA) or a combination of PMA and the calcium ionophore Ionomycin also induces secretion of growth factors without inducing proliferation, but in this case addition of IL 1 is ineffective in inducing AK-8 proliferation. Ionomycin 123-132 interleukin 1 complex Mus musculus 235-239 7879702-3 1994 Human recombinant tumour necrosis factor-alpha (TNF-alpha) and the calcium ionophores A23187 and ionomycin induced a concentration-dependent increase of cell-associated IL-1 but failed to cause release of IL-1 at concentrations producing maximal stimulation of cell-associated IL-1. Ionomycin 97-106 interleukin 1 complex Mus musculus 169-173 1688572-8 1990 The proliferative response induced in D10.G4 cells by IL-1 + ionomycin but not that induced by IL-1 + PMA was sensitive to inhibition by FK-506 and CsA. Ionomycin 61-70 interleukin 1 complex Mus musculus 54-58 3090144-5 1986 In the presence of either suboptimal levels of phorbol ester (PMA) or Ionomycin, the addition of IL 1 resulted in up to an 80-fold enhancement in the amount of IL 2 secreted. Ionomycin 70-79 interleukin 1 complex Mus musculus 97-101 3029093-6 1987 Both signal 1-type mediators, PHA and ionomycin, exerted pleiotropic effects at the concentrations required for synergy with signal 2-type mediators (IL1, TPA). Ionomycin 38-47 interleukin 1 complex Mus musculus 150-153 3100060-6 1986 Il-1 required the simultaneous presence of ionomycin and TPA to have any demonstrable effect on T lymphocytes from spleen and on thymocytes. Ionomycin 43-52 interleukin 1 complex Mus musculus 0-4